TNFSF12 and pancreatic neoplasm: The study also found that TWEAK expression was elevated in human PDAC patients with cachexia and that, higher TWEAK levels were associated with weight loss and cachectic status, underscoring TWEAK’s relevance as a cachexia mediator in pancreatic cancer [46].